9th Edition Clinical Trials in Canada

$499.00

SKU: PHP10489 Category:

Description

Report Code: PHP10489. April, 2010. Montreal, QC

ARTICLE I

Participant Protection Challenges: An International Perspective

Miriam Shuchman, MD
Associate Professor, University of Toronto
Psychiatry
Research Ethics Board Chair
Women’s College Research Institute

ARTICLE II

Optimizing a Recruitment Campaign

Paul Bergeron
Executive Vice President & General Manager
LxB Communications

ARTICLE III

Patient Recruitment: How To Overcome Negative Public Perception?

Karine Côté, BBA, RN
Associate Director, Operations and Recruitment
Q&T Research (Sherbrooke)

Pierre Gervais, B.Pharm, M.Sc.
President, Research Director – Q&T Research (Sherbrooke)
Research Director, Q&T Research (Outaouais)

ARTICLE IV

Pharmacokinetic and First-in-Man Studies: Safety in Healthy Volunteers

Pierre Geoffroy, MD, CM, MSc, F.C.F.P.
Medical Director and Principal Investigator
Biovail Contract Research

ARTICLE V

Use of Personal Information to Enhance Recruitment in Clinical Trials: Managing Privacy Expectations

Khaled El Emam, PhD
Associate Professor
Canada Research Chair in Electronic Health Information
University of Ottawa

Patricia Kosseim
Chief GE3LS Officer
Genome Canada

ARTICLE VI

So You Think You Know What An Informed Consent Is…

Margaret H. Kerr, B.A., LL.B., M.A., PhD
Barrister and Solicitor

ARTICLE VII

Strategy on Patient-Oriented Research

Peter Liu, MD
Scientific Director
Institute of Circulatory and Respiratory Health
Canadian Institutes of Health Research
Professor, Medicine and Physiology
Toronto General Hospital
University of Toronto

ARTICLE VIII

Patient Recruitment and Ethics: What Every Physicians Need To Know

Dr. Jeff Blackmer, MD MHSc FRCPC
Executive Director, Office of Ethics
Professionalism and International Affairs
Canadian Medical Association

ARTICLE IX

Clinical Trials and the Impact on a Physician’s Clinical Practice and Their Patients: A Physician’s Perspective

Pierre Geoffroy, MD, CM, MSc, F.C.F.P.
Medical Director, Principal Investigator
Biovail Contract Research

ARTICLE X

Health Canada Policy Review of the Management of Adverse Event Reports by Research Ethics Boards in Clinical Trials

Dr. Hoda Eid, Manager
Health Canada, Health Products and Food Branch
Therapeutic Products Directorate
Office of Clinical Trials – Adverse Drug Reaction Unit

ARTICLE XI

Changing Norms in Serious Adverse Event Reporting to REBs

Laurel Evans
Associate Director Research Ethics
University of British Columbia
Past President, CAREB

ARTICLE XII

Patient Safety and the Role of Research Ethics Boards

Susan Zimmerman
Executive Director
Interagency Secretariat on Research Ethics (Ottawa)

ARTICLE XIII

Strategies for Greater Web-Enabled Collaboration with the Patient

Jason Ridderikhoff, B.Sc.N.
Regional Operations Manager
Eli Lilly Canada Inc.

Rosa Deni
Training Account Leader
Eli Lilly & Company

ARTICLE XIV

Patients Retention Strategies in Long-Term Clinical Trials

Sandra Smyth
Trial Delivery Director, Oncology/Infection
AstraZeneca Canada Inc.

ARTICLE XV

Alzheimer’s Disease and Related Disorders

Teresa Anuza
Coordinator Intake and Referrals
Alzheimer Society of Montreal